Familial transmission of risk factors in the first-degree relatives of schizophrenic people

Biological Psychiatry

Volumn 47, Issue 3, 2000, Pages 231-239

  Waldo, Merilyne C ^a   Adler, Lawrence E ^a,b   Leonard, Sherry ^a,b   Olincy, Ann ^a,b   Ross, Randal G ^a,b   Harris, Josette G ^a,b   Freedman, Robert ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Dopamine; Genetics; Hippocampus; Inhibition; Nicotinic receptors; Smooth pursuit eye movements

Indexed keywords

DOPAMINE; NICOTINIC RECEPTOR;

FAMILIAL DISEASE; FAMILY; GENETIC RISK; HIPPOCAMPUS; HUMAN; INHERITANCE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RELATIVE; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SIBLING; SMOOTH PURSUIT EYE MOVEMENT;

BRAIN; DOPAMINE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HIPPOCAMPUS; HUMANS; PURSUIT, SMOOTH; RECEPTORS, NICOTINIC; SCHIZOPHRENIA;

EID: 0033984805     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(99)00272-3     Document Type: Review

References (83)

1. Adams C.E., Freedman R. Nicotinic antagonist α-bungarotoxin binding to rat hippocampal neurons containing nitric oxide synthase. Brain Res. 776:1997;111-116.
2. Adler L.E., Gerhardt G., Franks R., Baker N., Nagamoto H., Drebing C., et al. Sensory physiology and catecholamines in schizophrenia and mania. Psychiatry Res. 31:1990;297-309.
3. Adler L.E., Pachtman E., Franks R., Pecevich M., Waldo M.C., Freedman R. Neurophysiological evidence for a deficit in inhibitory mechanisms involved in sensory gating in schizophrenia. Biol Psychiatry. 17:1982;639-654.
4. Akbarian S., Vinuela A., Kim J.J., Potkin S.G., Bunney W.E. Jr, Jones E.G. Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase in temporal lobe of schizophrenics implies anomalous cortical development. Arch Gen Psychiatry. 50:1993;178-187.
5. Arolt V., Lencer R., Nolte A., Muller-Myhsok B., Purmann S., Schurmann M., et al. Eye tracking dysfunction is a putative phenotypic susceptibility marker of schizophrenia and maps to a locus on chromosome 6p in families with multiple occurrence of the disease. Am J Med Genet. 67:1996;564-579.
6. Baker N., Adler L.E., Franks R.D., Waldo M., Berry S., Nagamoto H., et al. Neurophysiological assessment of sensory gating in psychiatric inpatients Comparison between schizophrenia and other diagnoses . Biol Psychiatry. 22:1987;603-617.
7. Benes F.M., Kwok E.W., Vincent S.L., Todtenkopf M.S. A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives. Biol Psychiatry. 44:1998;88-97.
8. Blackwood D.H.R., St. Clair D.M., Muir W.J., Duffy J.C. Auditory P300 and eye tracking dysfunction in schizophrenic pedigrees. Arch Gen Psychiatry. 48:1991;899-909.
9. Boutros N.N., Zouridakis G., Overall J. Replication and extension of P50 findings in schizophrenia. Clin Electroencephalography. 22:1991;40-45.
10. Braff D.L., Geyer M.A. Sensorimotor gating and schizophrenia. Human and animal model studies. Arch Gen Psychiatry. 47:1990;181-188.
11. Breese C.R., Adams C., Logel J., Drebing C., Rollins Y., Barnhart M., et al. Comparison of the regional expression of nicotinic acetylcholine receptor α7 mRNA and [125]-α-bungarotoxin binding in the human postmortem brain. J Comp Neurology. 387:1997;385-398.
12. Broadbent D.E. Perception and Communication. 1958;Pergamon Press, New York.
13. Callicott J.H., Egan M.F., Bertolino A., Mattay V.S., Langheim F.J., Frank J.A., et al. Hippocampal N-acetyl aspartate in unaffected siblings of patients with schizophrenia A possible intermediate neurobiological phenotype . Biol Psychiatry. 44:1998;941-950.
14. Chini B., Raimond E., Elgoyhen A.B., Moralli D., Balzaretti M., Heinemann S. Molecular cloning and chromosomal localization of human α7-nicotinic receptor subunit gene (CHRNA7). Genomics. 19:1994;379-381.
15. Clementz B.A., Geyer M.A., Braff D.L. P50 suppression among schizophrenia and normal comparison subjects A methodological analysis . Biol Psychiatry. 41:1997;1035-1044.
16. Clementz B.A., Geyer M.A., Braff D.L. Poor P50 suppression among schizophrenia patients and their first-degree biological relatives. Am J Psychiatry. 155:1998;1691-1694.
17. Clementz B.A., Grove W.M., Iacono W.G., Sweeney J.A. Smooth-pursuit eye movement dysfunction and liability for schizophrenia Implications for genetic modeling . J Abnorm Psychol. 101:1992;117-129.
18. Clementz B.A., McDowell J.E., Zisook S. Saccadic system functioning among schizophrenic patients and their first-degree relatives. J Abnorm Psychol. 103:1994;277-287.
19. Clementz B.A., Sweeney J.A., Hirt M., Haas F. Pursuit gain and saccadic intrusions in first-degree relatives of probands with schizophrenia. J Abnorm Psychol. 99:1990;327-335.
20. Coon H., Plaetke R., Holik J., Hoff M., Myles-Worsley M., Freedman R., et al. Use of a neurophysiological trait in linkage analysis of schizophrenia. Biol Psychiatry. 34:1993;277-289.
21. Cowan N. Sensory memory and its role in information processing. Electroencephalogr Clin Neurophysiol Suppl. 44:1995;21-31.
22. Cullum C.M., Harris J.G., Waldo M.C., Smernoff E., Madison A., Nagamoto H.T., et al. Neurophysiological and neuropsychological evidence for attentional dysfunction in schizophrenia. Schizophrenia Res. 10:1993;131-141.
23. Curtis L, Blouin JL, Radhakrishna U, Gehrinf C, Lasseter VK, Wolyniec P, et al (1999): No evidence of linkage between schizophrenia and markers at chromosome 15q13-14. Am J Med0 Genet 88:109-112.
24. Eccles J.C. The Inhibitory Pathways of the Central Nervous System. 1969;Liverpool University Press, Liverpool, UK.
25. Edenberg H.J., Foroud T., Conneally P.M., Sorbel J.J., Carr K., Crose C., et al. Initial genomic scan of the NIMH genetics initiative bipolar pedigrees Chromosomes 3, 5, 15, 16, 17, and 22 . Am J Med Genet. 74:1997;238-246.
26. Erwin R.J., Mawhinney-Hee M., Gur R.C., Gur R.E. Midlatency auditory evoked responses in schizophrenia. Biol Psychiatry. 30:1991;430-442.
27. Erwin R.J., Turetsky B.I., Moberg P., Gur R.C., Gur R.E. P50 abnormalities in schizophrenia Relationship to clinical and neuropsychological indices of attention . Schizophrenia Res. 33:1998;157-168.
28. Franks R., Adler L.E., Waldo M., Alpert J., Freedman R. Neurophysiological studies of sensory gating in mania Comparison with schizophrenia . Biol Psychiatry. 18:1983;989-1005.
29. Freedman R., Adler L.E., Waldo M.C., Pachtman E., Franks R.D. Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia Comparison of medicated and drug-free patients . Biol Psychiatry. 18:1983;537-551.
30. Freedman R., Coon H., Myles-Worsley M., Orr-Urtreger A., Olincy A., Davis A., et al. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci. 94:1997;587-592.
31. Freedman R., Hall M., Adler L.E., Leonard S. Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biol Psychiatry. 38:1995;22-23.
32. Freedman R., Wetmore C., Stromberg I., Leonard S., Olson L. Alpha-bungarotoxin binding to hippocampal interneurons Immunocytochemical characterization and effects on growth factor expression . J Neurosci. 13:1993;1965-1975.
33. Gault J., Robinson M., Berger R., Drebing C., Logel J., Hopkins J., et al. Genomic organization and partial duplication of the human α7 neuronal nicotinic acetylcholine receptor gene (CHRNA7). Genomics. 52:1998;173-185.
34. Goldberg T.E., Torrey E.F., Berman D.F., Weinberger D.R. Relations between neuropsychological performance and brain morphological and physiological measures in monozygotic twins discordant for schizophrenia. Psychiatry Res. 55:1994;51-61.
35. Grove W.M., Clementz B.A., Iacono W.G., Katsanis J. Smooth pursuit ocular motor dysfunction in schizophrenia Evidence for a major gene . Am JPsychiatry. 149:1992;1362-1368.
36. Grove W.M., Lebow B.S., Clementz B.A., Cerri A., Medus C., Iacono W.G. Familial prevalence and co-aggregation of schizotypy indicators A multi-trait family study . J Abnorm Psychol. 100:1991;115-121.
37. Harris J.G., Adler L.E., Young D.A., Cullum C.M., Rilling L.M., Cicerello A., et al. Neuropsychological dysfunction in parents of schizophrenics. Schizophr Res. 20:1996;253-260.
38. Holzman P.S., Kringlen E., Matthysse S., Flanagan S.D., Lipton R.B., Cramer G., et al. A single dominant gene can account for eye tracking dysfunction and schizophrenia in offspring of discordant twins. Arch Gen Psychiatry. 45:1988;641-647.
39. Holzman P.S., Solomon C.M., Levin S., Waternaux C.S. Pursuit eye movement dysfunctions in schizophrenia. Arch Gen Psychiatry. 41:1984;136-139.
40. Holzman P.S. The use of eye movement dysfunctions in exploring the genetic transmission of schizophrenia. Arch Psychiatr Neurol Sci. 239:1989;43-48.
41. Hommer D.W., Radant A.D., Peng C. Oculomotor delayed response tasks in schizophrenia. Soc Neurosci Abstract. 17:1991;354.
42. Iacono W.G., Lykken W.T. Electro-oculographic recording and scoring of smooth pursuit and saccadc eye tracking A parametric study using monosygotic twins . Psychophysiology. 16:1979;94-107.
43. Iacono W.G., Lykken W.T. Eye tracking and psychopathology. Arch Gen Psychiatry. 36:1979;1361-1369.
44. Jin Y., Bunney W.E., Sandman C.A., Patterson J.V., Fleming K., Moenter J.R., et al. Is P50 suppression a measure of sensory gating in schizophrenia? Biol Psychiatry. 43:1998;873-878.
45. Jin Y., Potkin S.G., Patterson J.V., Sandman C.A., Hetrick W.P., Bunney W.E. Jr. Effects of P50 temporal variability on sensory gating in schizophrenia. Psychiatry Res. 70:1997;71-81.
46. Johnson S.W., Palmer M.R., Freedman R. Effects of dopamine on spontaneous and evoked activity of caudate neurons. Neuropharmacology. 22:1983;843-851.
47. Judd L.L., McAdams L., Budnick B., Braff D.L. Sensory gating deficit in schizophrenia New results . Am J Psychiatry. 149:1992;488-493.
48. Kendler K.S., Heninger G.R., Roth R.H. Brain contribution to the haloperidol-induced increase in plasmal homovanillic acid. Eur J Pharmacol. 71:1981;321-326.
49. Kraepelin E (1950): Dementia Praecox and Paraphrenia [Zinkin J, translator]. New York: International Universities Press.
50. Lawrie S.M., Whalley H., Kestelman J.N., Abukmeil S.S., Byrne M., Hodges A., et al. Magnetic resonance imaging of brain in people at high risk of developing schizophrenia. Lancet. 353:1999;30-33.
51. Leonard S., Gault J., Moore T., Hopkins J., Robinson M., Olincy A., et al. Further investigation of a chromosome 15 locus in schizophrenia Analysis of affected sibpairs from the NIMH genetics initiative . Neuropsychiatr Genet. 81:1998;308-312.
52. Levy D.L., Yasillo N.J., Dorus E., Shaughnessy R., Gibbons R.D., Peterson J. Relatives of unipolar and bipolar patients have normal pursuit. Psychiatry Res. 10:1983;282-293.
53. Lewis D.A., Akil M. Cortical dopamine in schizophrenia Strategies for postmortem studies . J Psychiatr Res. 31:1997;175-195.
54. Luntz-Leybman V., Bickford P., Freedman R. Cholinergic gating of response to auditory stimuli in rat hippocampus. Brain Res. 587:1992;130-136.
55. Meador-Woodruff J.H., Grandy D.K., Van Tol H.H., Damask S.P., Little K.Y., Civelli O., et al. Dopamine receptor gene expression in the human medial temporal lobe. Neuropsychopharmacology. 10:1994;239-248.
56. Myles-Worsley M., Tiobech J., Byerley W., Coon H. P50 Sensory gating in large schizophrenia families in Palau, Micronesia. Schizophr Res. 36:1999;247.
57. Nelson M.D., Saykin A.J., Flashman L.A., Riordan H.J. Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging A meta-analytic study . Arch Gen Psychiatry. 55:1998;433-440.
58. Neves-Pereira M., Bassett A.S., Honer W.G., Lang D., King N.A., Kennedy J.L. No evidence for linkage of the CRNA7 gene region in Canadian schizophrenia families. Am J Med Genet. 81:1998;361-363.
59. Park S., Holzman P.S. Schizophrenics show spatial working memory deficits. Arch Gen Psychiatry. 49:1992;975-982.
60. Pickar D., Labaraca R., Linnoila M., Roy A., Hommer D., Everett D., Paul S.M. Neuroleptic-induced decrease in plasma homovanillic acid and antipsychotic activity in schizophrenic patients. Science. 225:1984;954-957.
61. Pomper M.G., Webster M., Bobo L.D. Hippocampal α-7 nicotinic cholinergic receptor, neuronal nitric oxide synthase, and glutamic acid decarboxylase mRNA co-localization in schizophrenia. Schizophr Res. 36:1999;75.
62. Radant A.D., Hommer D.W. A quantitative analysis of saccades and smooth pursuit during visual pursuit tracking A comparison of schizophrenics with normals and substance abusing controls . Schizophr Res. 6:1992;225-235.
63. Reynolds G.P., Czudek C., Andrews H.B. Deficit and hemispheric asymmetry of GABA uptake sites in the hippocampus in schizophrenia. Biol Psychiatry. 27:1991;1038-1044.
64. Risch N. Linkage strategies for genetically complex traits. I. Multilocus models. Am J Hum Genet. 46:1990;222-228.
65. Rosenberg D.R., Sweeney J.A., Squires-Wheeler E., Keshavan M.S., Cornblatt B.A., Erlenmeyer-Kimling L. Eye tracking dysfunction in offspring from the New York High Risk Project Diagnostic specificity and the role of attention . Psychiatry Res. 66:1997;121-130.
66. Ross R.G., Harris J.G., Olincy A., Radant A., Adler L.E., Freedman R. Familial transmission of two independent saccadic abnormalities in schizophrenia. Schizophr Res. 30:1998;59-70.
67. Ross R.G., Hommer D.W., Radant A.D., Roath M., Freedman R. Early expression of smooth pursuit eye movement abnormalities in children of schizophrenic parents. J Am Acad Child Adolesc Psychiatry. 35:1996;941-949.
68. Ross R.G., Olincy A., Harris J.G., Radant A., Adler L.E., Freedman R. Anticipatory saccades during smooth pursuit eye movements and familial transmission of schizophrenia. Biol Psychiatry. 44:1998;690-697.
69. Ross R.G., Radant A.D., Hommer D.W. A developmental study of smooth pursuit eye movements in normal children from 7 to 15 years of age. J Child Adolesc Psychiatry. 32:1993;783-791.
70. Seigel C., Waldo M.C., Mizner G., Adler L.E., Freedman R. Deficits in sensory gating in schizophrenic patients and their relatives. Arch Gen Psychiatry. 41:1984;607-612.
71. Sereno A.B., Holzman P.S. Antisaccades and smooth pursuit eye movements in schizophrenia. Biol Psychiatry. 37:1995;394-401.
72. Steinkamp K., Heinemann U., Schmitz D. Dopamine suppresses stimulus-induced field potentials in layer III of rat medial entorhinal cortex. Neurosci Lett. 255:1998;119-121.
73. Strohman R. Epigensis The missing beat in biotechnology . Biotechnology. 12:1994;156-164.
74. Suddath R.L., Christison G.W., Torrey E.F., Casanova M.F., Weinberger D.R. Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia. N Engl J Med. 322:1990;789-794.
75. Venables P.H. The electrodermal psychophysiology of schizophrenics and children at risk for schizophrenia Controversies and developments . Schizophr Bull. 3:1977;28-48.
76. Vinogradov S., Solomon S., Ober B.A., Biggins C.A., Shenaut G.K., Fein G. Do semantic priming effects correlate with sensory gating inschizophrenia? Biol Psychiatry. 39:1996;821-824.
77. Waldo M., Cawthra E., Adler L.E., Dubester S., Staunton M., Nagamoto H., et al. Auditory sensory gating, hippocampal volume, and catecholamine metabolism in schizophrenics and their siblings. Schizophr Res. 12:1994;93-106.
78. Waldo M., Myles-Worsley M., Madison A., Byerley W., Freedman R. Sensory gating deficits in parents of schizophrenics. Am J Med Genet. 60:1995;506-511.
79. Waldo M.C., Adler L.E., Freedman R. Defects in auditory sensory gating and their apparent compensation in relatives of schizophrenics. Schizophr Res. 1:1988;19-24.
80. Waldo M.C., Carey G., Myles-Worsley M., Cawthra E., Adler L.E., Nagamoto H.T., et al. Co-distribution of a sensory gating deficit and schizophrenia in multi-affected families. Psychiatry Res. 39:1991;257-268.
81. Weinberger D.R. The biological basis of schizophrenia New directions . J Clin Psychiatry. 58:(suppl 10):1997;22-27.
82. Yee C.M., Nuechterlein K.H., Morris S.E., White P.M. P50 suppression in recent-onset schizophrenia Clinical correlates and risperidone effects . J Abnorm Psychol. 107:1998;691-698.
83. Young D., Waldo M., Rutledge J.H., Freedman R. Heritability of inhibitory gating of the P50 auditory evoked potential in monozygotic and dizygotic twins. Neuropsychobiology. 33:1996;113-117.